FTC sues main pharmacy benefit managers around insulin price ranges The company brought action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of existence-saving insulin medications. The deal need to be concluded by Sept. 30 or buyers https://ayahealthcareaddress92211.blog-gold.com/37904851/an-unbiased-view-of-healthcare-news